|
|
| Research article summary (published 18 Aug 2009): |
New ELISA for B cell-activating factor.
Full Abstract
BACKGROUND: The B cell-activating factor of the TNF family (BAFF) is upregulated in autoimmune diseases, but a number of conflicting results have cast doubts on the reliability of the ELISA protocols currently used for its quantification. This situation led us to develop a new ELISA for the measurement of BAFF. METHODS: BAFF was purified for use alongside nonglycosylated recombinant BAFF. Two monoclonal antibodies (mAbs) and two polyclonal antibodies (pAbs) to BAFF were used. RESULTS: The optimization process showed that the pAb format was preferable to the mAb format as capture antibody, because the pAbs recognized the glycosylated as well as the nonglycosylated forms of BAFF. The most efficient pair of Abs involved using the unconjugated form of a goat pAb to capture BAFF and the same biotinylated goat pAb to detect bound BAFF. This ELISA was not influenced by the presence of rheumatoid factor. CONCLUSIONS: This new ELISA helped provide insights into why serum concentrations of BAFF vary between studies for a given population of patients. It is a reliable tool for the management of the diseases in which BAFF is an indication of response to therapy.
Author information
Author/s: Le Pottier, Laëtitia (L); Bendaoud, Boutahar (B); Renaudineau, Yves (Y); Youinou, Pierre (P); Pers, Jacques-Olivier (JO); Daridon, Capucine (C);
Affiliation: EA 2216 Immunologie et Pathologie and IFR 418 ScInBioS, Université de Brest, Brest, France.
Journal and publication information
Publication Type: Journal Article
Journal: Clinical chemistry (Clin Chem), published in United States. (Language: eng)
Reference: 2009-Oct; vol 55 (issue 10) : pp 1843-51
Dates: Created 2009/09/29; Completed 2009/10/13;
PMID: 19696115, status: MEDLINE (last retrieval date: 10/13/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Development of a compact anti-BAFF antibody in Escherichia coli.
18 Apr 2006 - The CARI guidelines. Calcineurin inhibitors in renal transplantation: the addition of anti-CD25 antibody induction to standard immunosuppressive therapy for kidney transplant recipients.
30 Jan 2007 - Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody.
2 Oct 2007 - Construction and direct immunization of eukaryotic expression plasmid encoding human soluble B lymphocyte stimulator.
30 Dec 2005 - Construction and characterization of an enhanced GFP-tagged anti-BAFF scFv antibody.
20 Apr 2008 - Is BAFF the murderer in lupus?
29 Jun 2008 - A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells.
9 Jun 2008 - sBAFF mutants induce neutralizing antibodies against BAFF.
15 Jan 2007 - Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells.
11 Jul 2006 - Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF.
23 Oct 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.